<?xml version="1.0" encoding="UTF-8"?>
<p>Compounds 
 <bold>1</bold> and 
 <bold>2</bold> were isolated from LN303, yielding 4.95 mg of compound 
 <bold>1</bold> (purity 94%, estimated by analytical HPLC) and 0.83 mg of compound 
 <bold>2</bold> (&gt;90%). According to the LCâ€“MS analysis of the total extracts, both compounds were only detected in isolate LN303 (
 <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acsomega.0c05472/suppl_file/ao0c05472_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Figure S14</ext-link>) and were absent in all other investigated fungal extracts under the given growing conditions. We propose the names akanthenin A (
 <bold>1</bold>) and B (
 <bold>2</bold>) for these new compounds. Akanthenin A and B were most similar to the described compound YCM1008A, which can suppress Ca
 <sup>2+</sup>-induced growth inhibition in 
 <italic>S. cerevisiae</italic>.
 <sup>
  <xref ref-type="bibr" rid="ref15">15</xref>,
  <xref ref-type="bibr" rid="ref16">16</xref>
 </sup> Calcineurin inhibitors like, for example, cyclosporin, are valuable immunosuppressants used in the treatment of autoimmune diseases and organ transplants.
 <sup>
  <xref ref-type="bibr" rid="ref19">19</xref>
 </sup> Akanthomycin is another pyridone alkaloid that acts as an antibiotic and was described previously as being produced by 
 <italic>Akanthomyces gracilis</italic>;
 <sup>
  <xref ref-type="bibr" rid="ref20">20</xref>
 </sup> however, none of our total extracts contained this compound in detectable concentrations.
</p>
